Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:government_agency
|
| gptkbp:appliesTo |
approved drugs
|
| gptkbp:dataCollected |
healthcare providers
patients pharmaceutical companies |
| gptkbp:focusesOn |
post-market surveillance
drug safety |
| gptkbp:goal |
improve detection of adverse drug events
|
| https://www.w3.org/2000/01/rdf-schema#label |
Enhanced Monitoring Program
|
| gptkbp:implementedIn |
gptkb:U.S._Food_and_Drug_Administration
|
| gptkbp:monitors |
adverse events
|
| gptkbp:usedFor |
regulatory decision making
|
| gptkbp:bfsParent |
gptkb:Clean_Air_Act_Amendments_of_1990
|
| gptkbp:bfsLayer |
5
|